CDK2 and plasma cell myeloma: Collectively, these findings suggest that UNC13B may regulate multiple oncogenic and apoptotic signaling pathways—such as those involving PINK1, CDK2, AKR7A3, and Bim—to promote cell survival and proliferation in multiple myeloma.